Global Trust Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.1K Sell
117
-270
-70% -$24.1K ﹤0.01% 333
2026
Q1
$27.8K Buy
387
+300
+345% +$23.1K 0.01% 295
2025
Q4
$6.87K Sell
87
-37
-30% -$2.92K ﹤0.01% 358
2025
Q3
$9.38K Sell
124
-100
-45% -$6.85K ﹤0.01% 395
2025
Q2
$15.2K Hold
224
0.01% 352
2025
Q1
$14.9K Sell
224
-116
-34% -$6.94K 0.01% 331
2024
Q4
$15.3K Sell
340
-9,788
-97% -$549K 0.01% 378
2024
Q3
$637K Sell
10,128
-8,277
-45% -$483K 0.24% 95
2024
Q2
$1.09M Sell
18,405
-1,182
-6% -$73.9K 0.44% 59
2024
Q1
$1.56M Sell
19,587
-2,171
-10% -$166K 0.64% 39
2023
Q4
$1.72M Sell
21,758
-2,172
-9% -$155K 0.75% 35
2023
Q3
$1.67M Sell
23,930
-3,437
-13% -$244K 0.8% 32
2023
Q2
$1.89M Sell
27,367
-1,463
-5% -$104K 0.85% 30
2023
Q1
$2.14M Sell
28,830
-534
-2% -$44.8K 1.02% 22
2022
Q4
$2.74M Buy
29,364
+996
+4% +$96.1K 1.38% 19
2022
Q3
$2.71M Buy
28,368
+149
+0.5% +$14.7K 1.41% 17
2022
Q2
$2.62M Buy
28,219
+2,202
+8% +$215K 1.29% 20
2022
Q1
$2.63M Buy
26,017
+258
+1% +$27.1K 1.09% 21
2021
Q4
$2.66M Sell
25,759
-977
-4% -$90.3K 1.05% 22
2021
Q3
$2.27M Buy
26,736
+205
+0.8% +$17.2K 1.01% 23
2021
Q2
$2.21M Sell
26,531
-137
-0.5% -$11.2K 1.05% 19
2021
Q1
$2.01M Sell
26,668
-1,407
-5% -$102K 1.11% 20
2020
Q4
$1.92M Sell
28,075
-537
-2% -$34.9K 1.05% 21
2020
Q3
$1.66M Buy
28,612
+1,907
+7% +$119K 1.06% 22
2020
Q2
$1.74M Buy
26,705
+828
+3% +$52.1K 1.21% 21
2020
Q1
$1.54M Sell
25,877
-5
-0% -$334 1.21% 19
2019
Q4
$1.92M Hold
25,882
1.16% 18
2019
Q3
$1.63M Sell
25,882
-602
-2% -$35.7K 1.08% 20
2019
Q2
$1.44M Sell
26,484
-20
-0.1% -$1.08K 0.97% 21
2019
Q1
$1.43M Buy
26,504
+9,872
+59% +$609K 1.06% 21
2018
Q4
$1.09M Sell
16,632
-1,524
-8% -$114K 0.97% 25
2018
Q3
$1.43M Buy
18,156
+5,666
+45% +$405K 0.99% 22
2018
Q2
$804K Buy
12,490
+215
+2% +$14.2K 0.6% 46
2018
Q1
$764K Buy
12,275
+2,554
+26% +$183K 0.6% 46
2017
Q4
$705K Buy
+9,721
New +$707K 0.5% 58

Other funds holding CVS

Global Trust Asset Management's CVS Position: Q2 2026 in Review

Global Trust Asset Management reduced its CVS Health (CVS) stake by 70% in Q2 2026, selling an estimated $24.1K and leaving 117 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #333.

Global Trust Asset Management first reported a position in CVS in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.74M in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Global Trust Asset Management held 117 shares of CVS Health worth $12.1K as of Q2 2026.
  • Global Trust Asset Management sold 270 CVS Health shares in Q2 2026, an estimated $24.1K.
  • CVS Health made up ﹤0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #333 holding.
  • Global Trust Asset Management first reported a position in CVS Health in Q4 2017 and has held it in 35 quarters since.
  • Global Trust Asset Management's CVS Health position peaked at $2.74M in Q4 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.